103
Participants
Start Date
March 15, 2022
Primary Completion Date
May 2, 2025
Study Completion Date
May 2, 2025
Elagolix 200 MG
Elagolix tablet
Placebo or SOC IVF
Sugar pill manufactured to mimic Elagolix 200mg
Johns Hopkins, Division of Reproductive Science and Women's Health Research, Baltimore
Duke Fertility, Morrisville
Northwestern University Department of Obstetrics and Gynecology, Chicago
University of Colorado Department of Obstetrics & Gynecology, Aurora
Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences, New Haven
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
University of Colorado, Denver
OTHER
Northwestern University
OTHER
University of North Carolina
OTHER
Yale University
OTHER